213 related articles for article (PubMed ID: 14678602)
41. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
[TBL] [Abstract][Full Text] [Related]
42. Investigations into the role of anti-HLA class II antibodies in TRALI.
Kao GS; Wood IG; Dorfman DM; Milford EL; Benjamin RJ
Transfusion; 2003 Feb; 43(2):185-91. PubMed ID: 12559014
[TBL] [Abstract][Full Text] [Related]
43. Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.
Lakhashe SK; Thakar MR; Bharucha KE; Paranjape RS
J Virol; 2008 Jan; 82(1):428-34. PubMed ID: 17942547
[TBL] [Abstract][Full Text] [Related]
44. Class I and II HLA antibodies in pediatric patients with thalassemia major.
Yee ME; Shah A; Anderson AR; Boudreaux J; Bray RA; Gebel HM; Josephson CD
Transfusion; 2016 Apr; 56(4):878-84. PubMed ID: 26666394
[TBL] [Abstract][Full Text] [Related]
45. Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation.
Gatault P; Jollet I; Rabot N; Boulanger MD; Taupin JL; Barbet C; Baron C; Thierry A; Halimi JM; Lebranchu Y; Touchard G; Büchler M
Tissue Antigens; 2011 Oct; 78(4):241-8. PubMed ID: 21929572
[TBL] [Abstract][Full Text] [Related]
46. Anti-HLA class II antibodies and chronic allograft nephropathy.
Gerbase-DeLima M; Campos EF; Tedesco-Silva H; Machado PG; Franco M; Medina-Pestana JO
Clin Transpl; 2006; ():201-5. PubMed ID: 18365378
[TBL] [Abstract][Full Text] [Related]
47. Dynamic range of Nef-mediated evasion of HLA class II-restricted immune responses in early HIV-1 infection.
Mahiti M; Brumme ZL; Jessen H; Brockman MA; Ueno T
Biochem Biophys Res Commun; 2015 Jul; 463(3):248-54. PubMed ID: 25998395
[TBL] [Abstract][Full Text] [Related]
48. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
49. Major histocompatibility gene products and human immunodeficiency virus infection.
Puppo F; Ruzzenenti R; Brenci S; Lanza L; Scudeletti M; Indiveri F
J Lab Clin Med; 1991 Feb; 117(2):91-100. PubMed ID: 1993862
[TBL] [Abstract][Full Text] [Related]
50. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
51. Donor-specific sensitization by cadaveric venous allografts used for arterial reconstruction in peripheral arterial occlusive vascular disease.
Balzer KM; Luther B; Sandmann W; Wassmuth R
Tissue Antigens; 2004 Jul; 64(1):13-7. PubMed ID: 15191518
[TBL] [Abstract][Full Text] [Related]
52. Characterization of antiidiotypic antibodies to donor HLA that develop after liver transplantation.
Chauhan B; Phelan DL; Marsh JW; Mohanakumar T
Transplantation; 1993 Aug; 56(2):443-8. PubMed ID: 7689260
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
[TBL] [Abstract][Full Text] [Related]
54. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
55. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
Ahlers JD; Pendleton CD; Dunlop N; Minassian A; Nara PL; Berzofsky JA
J Immunol; 1993 Jun; 150(12):5647-65. PubMed ID: 8515081
[TBL] [Abstract][Full Text] [Related]
56. Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation.
Rebibou JM; Chabod J; Alcalay D; Coussediere MC; Deteix P; Touchard G; Dupont I; Thévenin C; Chalopin JM; Tiberghien P
Transplantation; 2002 Aug; 74(4):537-40. PubMed ID: 12352915
[TBL] [Abstract][Full Text] [Related]
57. Anti-leukocyte antibodies as a consequence of HIV infection in HIV+ individuals.
Riera NE; Galassi N; de la Barrera S; Rickard E; Muchinik G; Perez-Bianco R; de Bracco MM
Immunol Lett; 1992 Jun; 33(1):99-104. PubMed ID: 1427995
[TBL] [Abstract][Full Text] [Related]
58. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation.
Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F
J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748
[TBL] [Abstract][Full Text] [Related]
59. Clinical relevance of anti-HLA antibodies pre and post transplant.
Kerman RH; Orosz CG; Lorber MI
Am J Med Sci; 1997 May; 313(5):275-8. PubMed ID: 9145036
[TBL] [Abstract][Full Text] [Related]
60. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients.
Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz M
Transplantation; 1992 Jan; 53(1):181-9. PubMed ID: 1310170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
